Compass Therapeutics Inc. (CMPX)
Healthcare
Biotechnology
1.90 $
-1.3%
vs. previous close
Closing price · As of: 3. Aug 2026
Compass Therapeutics Inc. (CMPX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Operating Cash Flow" came in at -17 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
| Tick rows to compare them in a chart (up to 4) | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -10 | -5.9 | -12 | -14 | -11 | -11 | -9.2 | -13 | -12 | -11 | -13 | -17 | -53 | |
| 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.5 | 0.4 | 0.4 | -0.2 | 0.4 | -1.0 | 0.4 | -0.5 | |
| 1.6 | 1.6 | 1.6 | 2.0 | 2.1 | 2.2 | 2.2 | 2.5 | 2.8 | 1.2 | 1.8 | 5.1 | 11 | |
| 0.6 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.1 | 2.7 | -0.2 | -5.2 | 0.5 | -3.0 | 3.5 | 0.5 | 5.0 | 2.2 | 1.5 | -4.2 | 4.5 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | |
| -0.7 | 17 | 6.3 | -4.1 | 6.5 | 29 | 15 | 12 | -6.4 | -95 | -3.4 | 38 | -66 | |
| – | – | 0.0 | 0.0 | – | – | – | – | – | – | – | – | – | |
| 3.0 | 0.0 | -0.2 | 17 | 0.0 | 0.0 | -0.1 | -0.8 | 0.0 | 129 | 1.1 | 3.4 | 134 | |
| -7.7 | 11 | -6.2 | -0.6 | -4.3 | 18 | 6.1 | -2.4 | -18 | 23 | -16 | 25 | 14 | |
| -10 | -5.9 | -12 | -14 | -11 | -11 | -9.2 | -13 | -12 | -11 | -13 | -17 | -53 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.